Heka Global | $14,000,000 | (Jul 16, 2025)
Trupeer.ai | $3,000,000 | (Jul 16, 2025)
Crash Override | $28,000,000 | (Jul 16, 2025)
Certified by Founder
Lodge
ImmunoScape
start up
Singapore
- Singapore
- 26/09/2022
- Unknown
- $14,000,000
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company's proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery programs ongoing and will be progressing towards IND-enabling studies and entry into the clinic.
To learn more, visit us at immunoscape.com and follow us on Twitter @immunoscape.
- Industry Biotechnology Research
- Website https://immunoscape.com/
- LinkedIn https://www.linkedin.com/company/immunoscape/
Related People
Choon-Peng (Choon) NgFounder
Singapore -
Singapore
General Management. Cross functional and cross geography experience.
Heron Data | $16,000,000 | (Jul 16, 2025)
Tavrn | $15,000,000 | (Jul 16, 2025)
Covenant | $4,000,000 | (Jul 16, 2025)
Auriga Space | $6,000,000 | (Jul 16, 2025)
Dakota | $12,500,000 | (Jul 16, 2025)
Franzy | $2,200,000 | (Jul 16, 2025)
Fellow | $24,000,000 | (Jul 16, 2025)
IntuigenceAI | $10,000,000 | (Jul 16, 2025)